Antoine Leuzy

9.5k total citations · 3 hit papers
101 papers, 4.2k citations indexed

About

Antoine Leuzy is a scholar working on Physiology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Antoine Leuzy has authored 101 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Physiology, 70 papers in Psychiatry and Mental health and 33 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Antoine Leuzy's work include Alzheimer's disease research and treatments (70 papers), Dementia and Cognitive Impairment Research (65 papers) and Medical Imaging Techniques and Applications (19 papers). Antoine Leuzy is often cited by papers focused on Alzheimer's disease research and treatments (70 papers), Dementia and Cognitive Impairment Research (65 papers) and Medical Imaging Techniques and Applications (19 papers). Antoine Leuzy collaborates with scholars based in Sweden, United States and Canada. Antoine Leuzy's co-authors include Oskar Hansson, Agneta Nordberg, Konstantinos Chiotis, Niklas Mattsson, Elena Rodriguez‐Vieitez, Sebastian Palmqvist, Laëtitia Lemoine, Serge Gauthier, Pedro Rosa‐Neto and Erik Stomrud and has published in prestigious journals such as Nature, Nature Communications and Nature Neuroscience.

In The Last Decade

Antoine Leuzy

97 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau PET imaging in neurodegenerative tauopathies—still a challenge

2019 425 citations Antoine Leuzy, Konstantinos Chiotis et al. profile →
Blood‐based biomarkers for Alzheimer's disease

2021 196 citations Antoine Leuzy, Niklas Mattsson et al. profile →
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations

2021 171 citations Nicholas Cullen, Antoine Leuzy et al. Nature Communications profile →

Peers

Countries citing papers authored by Antoine Leuzy

Since Specialization

Citations

This map shows the geographic impact of Antoine Leuzy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Leuzy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Leuzy more than expected).

Fields of papers citing papers by Antoine Leuzy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Leuzy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Leuzy. The network helps show where Antoine Leuzy may publish in the future.

Co-authorship network of co-authors of Antoine Leuzy

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Leuzy. A scholar is included among the top collaborators of Antoine Leuzy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Leuzy. Antoine Leuzy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of Alzheimer’s disease pathology in the community 2025 ·Nature ·Dag Aarsland, A. Sunde, Diego Tovar, Antoine Leuzy, Tormod Fladby, Henrik Zetterberg, Kaj Blennow, (unknown), (unknown), (unknown), Burak Arslan, Hanna Huber, (unknown), (unknown), Guglielmo Di Molfetta, Håvard Kjesbu Skjellegrind, Geir Selbæk, Nicholas J. Ashton	1
2	Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease 2025 ·Alzheimer s & Dementia ·Antoine Leuzy, Ariane Bollack, Daniela Pellegrino, Charlotte E. Teunissen, Renaud La Joie, Gil D. Rabinovici, Nicolai Franzmeier, Keith A. Johnson, Frederik Barkhof, Leslie M. Shaw, (unknown), Suzanne E. Schindler, Lawrence S. Honig, Alexis Moscoso, Michael Schöll, Henrik Zetterberg, Kaj Blennow, Oskar Hansson, Gill Farrar	9
3	REAL AD—Validation of a realistic screening approach for early Alzheimer's disease 2024 ·Alzheimer s & Dementia ·Antoine Leuzy, Fiona Heeman, (unknown), (unknown), (unknown), (unknown), Alexis Moscoso, Silke Kern, (unknown), Kaj Blennow, Michael Schöll	5
4	Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment 2024 ·JAMA Neurology ·Colin Groot, Ruben Smith, Lyduine E. Collij, Sophie E Mastenbroek, Erik Stomrud, Alexa Pichet Binette, Antoine Leuzy, Sebastian Palmqvist, Niklas Mattsson, Olof Strandberg, Hanna Cho, Chul Hyoung Lyoo, Giovanni B. Frisoni, Débora Elisa Peretti, Valentina Garibotto, Renaud La Joie, David N. Soleimani‐Meigooni, Gil D. Rabinovici, Rik Ossenkoppele, Oskar Hansson	21
5	Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes 2023 ·Alzheimer s & Dementia ·Antoine Leuzy, Niklas Mattsson, Nicholas Cullen, Erik Stomrud, Sebastian Palmqvist, Renaud La Joie, Leonardo Iaccarino, Henrik Zetterberg, Gil D. Rabinovici, Kaj Blennow, Shorena Janelidze, Oskar Hansson	16
6	Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy 2022 ·Parkinsonism & Related Disorders ·(unknown), (unknown), Antoine Leuzy, Shorena Janelidze, Sara Hall, Oskar Hansson, Ruben Smith	10
7	Sex differences in off-target binding using tau positron emission tomography 2021 ·NeuroImage Clinical ·Ruben Smith, Olof Strandberg, Antoine Leuzy, Tobey J. Betthauser, Sterling C. Johnson, Joana B. Pereira, Oskar Hansson	24
8	A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Antoine Leuzy, Tharick A. Pascoal, Olof Strandberg, Philip S. Insel, Ruben Smith, Niklas Mattsson, Andréa Lessa Benedet, Hanna Cho, Chul Hyoung Lyoo, Renaud La Joie, Gil D. Rabinovici, Rik Ossenkoppele, Pedro Rosa‐Neto, Oskar Hansson	57
9	Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations breakdown → 2021 ·Nature Communications ·Nicholas Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson, Oskar Hansson	171
10	An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders 2020 ·Nature Reviews Neurology ·Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, (unknown), Marc Suárez‐Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg, Dag Aarsland	125
11	Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease — Learnings from brain imaging biomarkers 2020 ·International review of neurobiology ·Kerstin Heurling, Edvin Johansson, Antoine Leuzy	7
12	Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [18F]THK5317 PET 2019 ·NeuroImage Clinical ·My Jonasson, Anders Wall, Konstantinos Chiotis, Antoine Leuzy, Jonas Eriksson, Gunnar Antoni, Agneta Nordberg, Mark Lubberink	2
13	Synaptic vesicle protein 2A as a potential biomarker in synaptopathies 2019 ·Molecular and Cellular Neuroscience ·Kerstin Heurling, Nicholas J. Ashton, Antoine Leuzy, Eduardo R. Zimmer, Kaj Blennow, Henrik Zetterberg, Jonas Eriksson, Mark Lubberink, Michael Schöll	58
14	[18F]FDG PET signal is driven by astroglial glutamate transport 2017 ·Nature Neuroscience ·Eduardo R. Zimmer, Maxime Parent, Débora Guerini de Souza, Antoine Leuzy, Clotilde Lecrux, Hyoung-Ihl Kim, Serge Gauthier, Luc Pellerin, Édith Hamel, Pedro Rosa‐Neto	228
15	Quantitative positron emission tomography in brain research 2017 ·Brain Research ·Kerstin Heurling, Antoine Leuzy, My Jonasson, Andreas Frick, Eduardo R. Zimmer, Agneta Nordberg, Mark Lubberink	27
16	Epistasis analysis links immune cascades and cerebral amyloidosis 2015 ·Journal of Neuroinflammation ·(unknown), Andréa Lessa Benedet, Aurélie Labbe, Philippe Lemay, Eduardo R. Zimmer, Tharick A. Pascoal, Antoine Leuzy, Sulantha Mathotaarachchi, (unknown), Monica Shin, Alexandre Dionne‐Laporte, Thomas Beaudry, Cynthia Picard, Serge Gauthier, Judes Poirier, Guy A. Rouleau, Pedro Rosa‐Neto	11
17	In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD 2015 ·Brain Structure and Function ·Antoine Leuzy, Eduardo R. Zimmer, Jonathan M. DuBois, Jens C. Pruessner, (unknown), Jean‐Paul Soucy, Alexey Kostikov, (unknown), René Desautels, Serge Gauthier, Pedro Rosa‐Neto	26
18	Amyloid imaging in Alzheimer’s disease: a potential new era of personalized medicine? 2014 ·Translational Neuroscience ·Antoine Leuzy, Eduardo R. Zimmer, Serge Gauthier, Pedro Rosa‐Neto	2
19	Developments in Tau PET Imaging 2014 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Eduardo R. Zimmer, Antoine Leuzy, Serge Gauthier, Pedro Rosa‐Neto	42
20	Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment 2012 ·PLoS ONE ·Liyong Wu, Jared Rowley, (unknown), Antoine Leuzy, (unknown), Monica Shin, Vladimir Fonov, Jianping Jia, Serge Gauthier, Pedro Rosa‐Neto, (unknown)	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact